New ACRO chief wants to focus on training future researchers; U.S. wants exemption from EU API regs;

> Parexel International ($PRXL) CEO Josef von Rickenbach is the new chief of the trade group ACRO, and he says the organization needs to focus on ensuring that the booming CRO industry has enough trained researchers to keep growing. Story

> The EU is planning to impose new rules on imported APIs, and the U.S. wants to be added to a list of exempt countries presumed to enforce their own good manufacturing practices. Article

> CRO K&L Consulting Services is partnering with Medidata Solutions ($MDSO) to offer cloud-based clinical data management as part of its biostatistical platform. More

> Chinese CRO MicroConstants has inked a deal to manage trials at the No. 307 Hospital of People's Liberation Army, looking to turn the large Chinese center into a contract research powerhouse that complies with international standards. Release

> German CRO Verum.de, which has a new office in Carlsbad, CA, has been picked to run clinical trials at the Center for Oncologic Diagnosis and Treatment, a privately funded Romanian facility seeking to develop cancer treatments. Item

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.